查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466749

临床微生物学市场：按产品类型、检体类型、最终用户、应用划分 - 全球预测 2024-2030

Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年临床微生物学市场规模为78亿美元，预计2024年将达86.8亿美元，2030年将达到161.2亿美元，复合年增长率为10.91%。

临床微生物学涵盖广泛的实验室方法，并且在生物体以及用于分离和鑑定它们的方法方面很复杂。临床微生物学重点研究引起感染疾病的微生物，分离和鑑定细菌、病毒、寄生虫和真菌等传染性生物体，以及管理和治疗患者。感染疾病率的增加、疾病预防意识的增强以及医疗保健成本的上升正在推动临床微生物学的使用。临床微生物实验室品质保证和管理方面的挑战，加上设备和基础设施的有限性，可能会阻碍产品渗透到市场。此外，临床微生物学设备和製程的技术进步为医学检测企业扩大其产品组合和提高盈利提供了各种机会。

主要市场统计
基准年[2023] 78亿美元
预测年份 [2024] 86.8亿美元
预测年份 [2030] 161.2亿美元
复合年增长率（%） 10.91%

实验室设备在产品临床微生物学评估中的使用

培养箱、生物安全柜、离心机、显微镜等实验室设备在临床微生物学评估中有着广泛的应用。临床微生物学家更喜欢专门的试剂和分析设备来培养、检测、可视化和识别微生物，如细菌、古细菌、病毒、真菌和原生动物。临床试剂和分析仪有助于研究微生物的型态、结构、分类、遗传变异、生理和生化，以进行快速临床诊断。

检体类型 血清样本是血清学检体的首选，以检测过去或目前的感染疾病。

血液检体对于检测引起败血症、心内膜炎和其他全身性感染疾病的血源性病原体至关重要。胸腔积水、腹水和心包膜液等体液对于浆膜腔感染疾病的诊断至关重要。脑脊髓液检体对于诊断脑膜炎和脑炎等中枢神经系统感染疾病至关重要。粪便检体对于诊断胃肠道感染疾病和监测肠道病原体的抗菌药物抗药性至关重要。唾液检体最近作为诊断呼吸道感染疾病（包括 COVID-19）的传统方法的非侵入性替代方法而受到关注。血清检体对于透过测量病原体特异性抗体来检测过去或目前感染疾病的血清学测试至关重要。

最终使用者：实验室和研究机构采用临床微生物学可以详细了解感染疾病状况。

临床微生物学评估是在临床实验室、医院/医疗机构、学术/研究机构中进行的，以分离和表征感染性微生物，以有效诊断疾病状态。实验室和研究机构利用临床微生物学技术为医疗保健专业人员提供对感染疾病的详细了解。

应用 透过识别致病病原体，更多地使用临床微生物学来诊断胃肠道 (GI) 疾病

自体免疫疾病，包括类风湿性关节炎和狼疮，是免疫系统攻击健康细胞的疾病。临床微生物学透过识别特定的自身抗体和发炎标记物来帮助诊断这些疾病。临床微生物学的心臟科应用包括诊断影响心血管系统的感染疾病，例如心内膜炎和心肌炎。快速识别病原体可以实现标靶治疗并改善结果。临床微生物学透过识别可能影响血糖控製或引起併发症的感染疾病（例如由金黄色葡萄球菌等细菌引起的尿道感染和足部溃疡）在糖尿病管理中发挥作用。在药物测试中，临床微生物学监测抗菌素抗药性模式并确保在感染疾病治疗中选择适当的治疗方法。临床微生物学透过识别幽门螺旋桿菌和艰难梭菌等致病病原体，有助于胃肠道 (GI) 疾病的诊断。肾臟科特异性微生物检测可诊断肾臟相关感染疾病，例如肾盂肾炎，需要特定的抗生素治疗。临床微生物学中的肿瘤学应用可诊断癌症相关感染疾病，这些感染可能会影响治疗计划或导致併发症。在牙周病中，临床微生物学帮助牙医识别口腔中引起牙龈炎和牙周炎等疾病的病原体，使他们能够选择适当的治疗方法。

区域洞察

在北美，主导市场参与者的存在、研发投资的增加以及感染疾病的流行正在显着推动临床微生物学的采用。在美国，製药和医疗保健领域高度发达，刺激了先进临床诊断技术的采用。开拓靶向聚合酵素链锁反应(PCR) 等新型创新微生物技术，以提高成本效益并改善临床结果，正在加强该地区临床微生物学市场的成长。在亚太地区，广谱诊断和分子诊断越来越受欢迎，以提高诊断灵敏度和时间效率，为临床微生物学的发展做出了重大贡献。蓬勃发展的医疗旅游业预计将推动印度、中国、泰国和马来西亚等亚洲国家对微生物诊断和监测测试的需求。在欧洲地区，致病性疾病数量的不断增加、适应性细菌的不断发现以及对快速微生物检测方法的需求不断增长正在推动临床微生物学技术的使用。

FPNV定位矩阵

FPNV定位矩阵对于评估临床微生物学市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对临床微生物学市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 临床微生物学市场的市场规模与预测是多少？

2.在临床微生物学市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3. 临床微生物学市场的技术趋势和法规结构是什么？

4.临床微生物市场主要厂商的市场占有率为何？

5. 进入临床微生物市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加临床微生物学在感染疾病管理与控制的应用
      • 政府和私人组织对癌症诊断和研究的积极支持和努力
    • 抑制因素
      • 缺乏熟练的专业人员、设备和基础设施
    • 机会
      • 临床微生物学产品和製程的技术进步
      • 照护现场微生物检测简介
    • 任务
      • 临床微生物实验室的品质保证与控制问题
  • 市场区隔分析
    • 产品：实验室设备在临床微生物学评估中的使用
    • 检体类型：首选血清样本进行血清学检测，以检测过去或目前的感染情况
    • 最终用户：在实验室和研究中应用临床微生物学，提供有关感染疾病病理学的详细信息
    • 应用：识别致病病原体增加了临床微生物学在胃肠道疾病诊断的应用
  • 市场趋势分析
    • 不断开发先进临床微生物学测试的成熟市场供应商的存在
    • 亚太地区感染疾病流行与临床微生物学产品的改进
    • 政府的支持努力和正在进行的研究，以克服欧洲、中东和非洲地区的感染疾病负担
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章临床微生物学市场：副产品

  • 装置
  • 试剂

第七章临床微生物学市场样本类型

  • 血
  • 体液
  • 脑脊髓液
  • 屎
  • 唾液
  • 血清
  • 滑液
  • 尿

第八章临床微生物学市场：依最终使用者分类

  • 学术研究所
  • 医院和护理提供者
  • 研究机构

第九章临床微生物学市场：依应用分类

  • 自体免疫疾病
  • 心臟病学
  • 糖尿病
  • 药检
  • 消化系统疾病
  • 肾臟病学
  • 肿瘤学
  • 牙周疾病
  • 呼吸系统疾病
  • 性行为感染传染病

第十章美洲临床微生物学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太临床微生物学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲临床微生物学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 威奇托州立大学 MDL 实验室转向微生物学。
    • 剑桥Start-Ups赢得了开发新诊断技术的资金。
    • 微生物学会与印度班加罗尔科学研究所签署转型协议
    • Hardy Diagnostics 与 Premier 签署手册微生物学协议
    • 医学微生物学系推出了四个总价值 680 万美元的新计划和一个新网站。
    • ASM 资助包容性微生物学领导计画。
    • MAESTRIA 是 Biomerieux 开发的新一代微生物学中间件，可优化实验室工作流程并改善患者照护。
    • Beckman Coulter 和 MeMed 将扩大经过验证的宿主免疫反应诊断的使用范围，这些诊断可以区分病毒和细菌感染。
    • BD 为微生物实验室安装全自动机器人轨道系统。
    • FASTinov 与 Beckman Coulter Life Sciences 合作，将超快 2h-AST 创新技术引入临床微生物实验室。
    • 北部计划开设一个莱姆病和蜱传疾病的多学科治疗中心。
    • Bio-Rad 扩大了 Abbott 诊断平台的品质控制覆盖范围。
    • 联邦资金将增强亚伯达大学应对高传染性病原体的能力。
    • 牛津大学获得 1.22 亿英镑（1.3663 亿美元）的医疗保健研究资金。
    • Sci-Tech Daresbury 旗下的 Perfectus Biomed Group 已被医疗设备测试领域的全球领导者 NAMSA 收购。
    • HORIBA Veterinary 为难以诊断的寄生虫增加了新的快速 PCR 检测。
    • ValitaCell 加入贝克曼库尔特生命科学公司。
    • Global Access Diagnostics 从 Bio-Rad Laboratories 获得了 IT-LEISH 快速诊断测试的製造权。
    • SSI Diagnostica 持续强劲成长。
    • BD 和 Accelerate Diagnostics 宣布建立全球商业合作伙伴关係。
    • SGS 在亚利桑那州凤凰城开设了一个新的微生物实验室。
    • 以色列：欧盟向以色列微生物诊断公司 Pocared 提供 2,200 万欧元（2,426 万美元）。
    • DCN Dx 收购微生物检测产品公司 Biomed Diagnostics。
    • 生物梅里埃透过收购 Specific Diagnostics （创新企业），加强了对抗抗菌素抗药性的努力。
    • 美国国立卫生研究院 (NIH) 资助新的结核病研究和发展中心。
    • Raue 为 Sonic Healthcare 收购 Diagnosticum Laboratory Group 提供顾问服务。
    • ATCC 宣布与 QIAGEN 建立合作伙伴关係，以扩展其生物资讯资料平台。
    • Hardy Diagnostics 现在提供 BioCode MDx-3000。
    • 默克宣布对其生命科学业务部门进行组织变革，以加强其 CDMO 产品并加速未来成长。
    • COPAN Diagnostics 宣布临床微生物学人工智慧发展又迈出了重要一步。

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4312A385A416

[189 Pages Report] The Clinical Microbiology Market size was estimated at USD 7.80 billion in 2023 and expected to reach USD 8.68 billion in 2024, at a CAGR 10.91% to reach USD 16.12 billion by 2030.

Clinical microbiology encompasses a wide range of testing methods, and it is complex in terms of organisms and methods used to isolate & identify them. Clinical microbiology investigates microorganisms that cause infectious diseases and focuses on isolating and characterizing infectious organisms such as bacteria, viruses, parasites, and fungi to manage and treat patients. The increasing occurence of infectious diseases, growing awareness of disease prevention, and increasing healthcare expenditure are all factors driving the use of clinical microbiology. Problems concerning quality assurance and management in clinical microbiology laboratories coupled with limited availability of equipment and infrastructure can pose a challenge to product penetration in the market. Additionally, technological advancement in clinical microbiology instruments and processes presents various opportunities for medical laboratory businesses to expand their portfolio and increase profitability.

KEY MARKET STATISTICS
Base Year [2023] USD 7.80 billion
Estimated Year [2024] USD 8.68 billion
Forecast Year [2030] USD 16.12 billion
CAGR (%) 10.91%

Product: Use of laboratory instruments in clinical microbiology assessments

Laboratory instruments such as incubators, biosafety cabinets, centrifuges, and microscopes include a wide scope of applications in clinical microbiology assessments. Clinical microbiologists prefer specialized reagents & analyzers to culture, detect, visualize, and identify microscopic organisms such as bacteria, archaea, viruses, fungi, or protozoa. Clinical reagents & analyzers aid in studying the morphology, structure, classification, genetic variation, physiology, and biochemistry of microorganisms for rapid clinical diagnostics.

Specimen Type: Preference for serum samples in serological testing to detect past or current infections

Blood specimens are essential for detecting bloodborne pathogens responsible for sepsis, endocarditis, and other systemic infections. Body fluids such as pleural, peritoneal, or pericardial fluid are crucial for diagnosing infections in serous cavities. CSF specimens are critical in diagnosing central nervous system infections, including meningitis or encephalitis. Fecal specimens are crucial for diagnosing gastrointestinal infections and monitoring antimicrobial resistance in enteric pathogens. Saliva specimens have gained attention in recent years as non-invasive alternatives to traditional methods for diagnosing respiratory infections, including COVID-19. Serum samples are essential for serological testing to detect past or current infections by measuring pathogen-specific antibodies.

End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions

Clinical microbiology assessments are performed at clinical laboratories, hospitals & care providers, and academic & research institutes to isolate and characterize infectious organisms for diagnosing disease conditions effectively. Laboratories and research institutes provide detailed insights regarding infectious disease conditions to healthcare professionals using clinical microbiology techniques.

Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens

Autoimmune diseases, including rheumatoid arthritis and lupus, involve the immune system attacking healthy cells. Clinical microbiology helps diagnose these conditions by identifying specific autoantibodies or inflammatory markers. Cardiology applications in clinical microbiology include diagnosing infections that affect the cardiovascular system, such as endocarditis and myocarditis. Rapid identification of pathogens enables targeted treatment and improved outcomes. Clinical microbiology plays a role in diabetes management by identifying infections that may impact blood glucose control or cause complications, such as urinary tract infections or foot ulcers infected by bacteria such as Staphylococcus aureus. In drug testing, clinical microbiology monitors antimicrobial resistance patterns to ensure appropriate therapeutic choices for infectious disease treatment. Clinical microbiology contributes to diagnosing gastrointestinal (GI) diseases by identifying causative pathogens, such as Helicobacter pylori or Clostridioides difficile. Nephrology-focused microbiology tests diagnose kidney-related infections, such as pyelonephritis, which requires specific antimicrobial therapies. Oncology applications within clinical microbiology involve diagnosing cancer-related infections that can compromise treatment plans or contribute to complications. In periodontal diseases, clinical microbiology helps dentists identify oral pathogens responsible for conditions such as gingivitis and periodontitis, enabling appropriate treatment selection.

Regional Insights

In North America, the strong presence of leading market players, increasing investments in research & development, and the growing prevalence of infectious diseases significantly increase the adoption of clinical microbiology. Highly developed pharmaceutical and healthcare sectors in the United States are fueling the adoption of advanced clinical diagnostic techniques. Developing new and innovative microbiological technologies, such as targeted polymerase chain reactions (PCRs), to increase cost-effectiveness and improve clinical outcomes is strengthening the market growth of clinical microbiology across the region. In Asia-Pacific, the growing popularity of broad-range and molecular diagnosis to surge the sensitivity of diagnosis while promoting time effectiveness significantly contributes to the development of clinical microbiology. The booming medical tourism industry is expected to increase the need for microbial diagnostic and monitoring tests in Asian countries such as India, China, Thailand, and Malaysia. In the Europe region, the increasing prevalence of pathogenic diseases, growth in the discovery of adapting bacterium, and the rising need for speedy microbiological testing methods enhance the utilization of clinical microbiology technology.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Microbiology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Microbiology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Instruments, LLC, Agilent Technologies, Inc., B. Braun SE, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Cardinal Health, Inc., Clinichem Ltd., COPAN Diagnostics Inc., Diagnostica Longwood S.L., ELITech Group, F. Hoffmann-La Roche Ltd., Hardy Diagnostics, HORIBA, Ltd., Kyokuto Pharmaceutical Industrial Co., Ltd., Laboratorios Conda, S.A., Liofilchem S.r.l., Merck KGaA, Prestige Diagnostics U.K. Ltd., Pro Lab Diagnostics Inc., QIAGEN N.V., Rapid Micro Biosystems, Inc., Shimadzu Corporation, SSI Diagnostica A/S, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Vircell S.L..

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents
  • Specimen Type
    • Blood
    • Body fluids
    • Cerebrospinal Spinal Fluid
    • Fecal
    • Saliva
    • Serum
    • Synovial Fluid
    • Urine
  • End-User
    • Academic & Research Institutes
    • Hospitals & Care Providers
    • Laboratories
  • Application
    • Autoimmune Diseases
    • Cardiology
    • Diabetes
    • Drug Testing
    • Gastrointestinal Diseases
    • Nephrology
    • Oncology
    • Periodontal Diseases
    • Respiratory Diseases
    • Sexually Transmitted Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Microbiology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Microbiology Market?

3. What are the technology trends and regulatory frameworks in the Clinical Microbiology Market?

4. What is the market share of the leading vendors in the Clinical Microbiology Market?

5. Which modes and strategic moves are suitable for entering the Clinical Microbiology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
      • 5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in clinical microbiology products and processes
      • 5.1.3.2. Introduction of point-of-care microbiology testing
    • 5.1.4. Challenges
      • 5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
    • 5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
    • 5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
    • 5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
  • 5.3. Market Trend Analysis
    • 5.3.1. Presence of well-established market vendors with the ongoing development of advanced clinical microbiology testings
    • 5.3.2. Prevalence of infectious disease and improvements in clinical microbiology products in APAC
    • 5.3.3. Supportive government initiatives and ongoing research to overcome the burden of infectious diseases in the EMEA region
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Clinical Microbiology Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents

7. Clinical Microbiology Market, by Specimen Type

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Body fluids
  • 7.4. Cerebrospinal Spinal Fluid
  • 7.5. Fecal
  • 7.6. Saliva
  • 7.7. Serum
  • 7.8. Synovial Fluid
  • 7.9. Urine

8. Clinical Microbiology Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Hospitals & Care Providers
  • 8.4. Laboratories

9. Clinical Microbiology Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
  • 9.3. Cardiology
  • 9.4. Diabetes
  • 9.5. Drug Testing
  • 9.6. Gastrointestinal Diseases
  • 9.7. Nephrology
  • 9.8. Oncology
  • 9.9. Periodontal Diseases
  • 9.10. Respiratory Diseases
  • 9.11. Sexually Transmitted Diseases

10. Americas Clinical Microbiology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Microbiology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Microbiology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Wichita State's MDL Lab Shifting To Microbiology.
    • 13.3.2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
    • 13.3.3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
    • 13.3.4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
    • 13.3.5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
    • 13.3.6. ASM Funded for Inclusive Microbiology Leaders Program.
    • 13.3.7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomerieux to Optimize Laboratory Workflow and Improve Patient Care.
    • 13.3.8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
    • 13.3.9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
    • 13.3.10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
    • 13.3.11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
    • 13.3.12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
    • 13.3.13. Federal Funds Set To Boost U of A's Ability To Handle Highly Infectious Pathogens.
    • 13.3.14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
    • 13.3.15. Sci-Tech Daresbury's Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
    • 13.3.16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
    • 13.3.17. ValitaCell Joins Beckman Coulter Life Sciences.
    • 13.3.18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
    • 13.3.19. SSI Diagnostica Continues a Strong Growth Journey.
    • 13.3.20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
    • 13.3.21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
    • 13.3.22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
    • 13.3.23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
    • 13.3.24. bioMerieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
    • 13.3.25. NIH Funded New Tuberculosis Research Advancement Centers.
    • 13.3.26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
    • 13.3.27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
    • 13.3.28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
    • 13.3.29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
    • 13.3.30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 229. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 314. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 315. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 324. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 325. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 330. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 331. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 342. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 343. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. SOUTH AFRICA CLINICAL MICROBIOLOGY